NasdaqCM - Delayed Quote • USD
Celldex Therapeutics, Inc. (CLDX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 190.62k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| JIMENEZ FREDDY A General Counsel | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 93,163 | Feb 13, 2024 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.78 per share. | Direct | 29,885 | Jan 2, 2024 |
| KELER TIBOR Officer | Sale at price 36.93 per share. | Direct | 622,611 | Dec 7, 2022 |
| KELER TIBOR Officer | Conversion of Exercise of derivative security at price 2.78 per share. | Direct | 46,871 | Dec 7, 2022 |
| CAVANAUGH SARAH Officer | Sale at price 36.38 - 36.73 per share. | Direct | 1,199,510 | Aug 18, 2022 |
| CAVANAUGH SARAH Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 99,265 | Aug 18, 2022 |
| YOUNG DIANE C Officer | Sale at price 37.30 per share. | Direct | 708,715 | Aug 17, 2022 |
| YOUNG DIANE C Officer | Conversion of Exercise of derivative security at price 2.71 - 10.38 per share. | Direct | 319,170 | Aug 17, 2022 |
| MARUCCI ANTHONY S Chief Executive Officer | Sale at price 37.66 per share. | Direct | 4,519,572 | Aug 15, 2022 |
| MARUCCI ANTHONY S Chief Executive Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 614,242 | Aug 15, 2022 |
| WRIGHT RICHARD M Officer | Sale at price 37.71 per share. | Direct | 578,048 | Aug 15, 2022 |
| WRIGHT RICHARD M Officer | Conversion of Exercise of derivative security at price 10.38 per share. | Direct | 159,105 | Aug 15, 2022 |
| MARTIN SAMUEL BATES Chief Financial Officer | Sale at price 34.62 - 37.04 per share. | Direct | 730,485 | Aug 12, 2022 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 95,071 | Aug 12, 2022 |
| MARTIN SAMUEL BATES Chief Financial Officer | Sale at price 42.00 per share. | Direct | 399,000 | Dec 23, 2021 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 39,729 | Dec 23, 2021 |
| CROWLEY ELIZABETH Officer | Sale at price 40.00 per share. | Direct | 160,000 | Dec 8, 2021 |
| CROWLEY ELIZABETH Officer | Conversion of Exercise of derivative security at price 9.02 per share. | Direct | 36,066 | Dec 8, 2021 |
| CAVANAUGH SARAH Officer | Sale at price 40.00 per share. | Direct | 292,920 | Dec 8, 2021 |
| CAVANAUGH SARAH Officer | Conversion of Exercise of derivative security at price 9.02 - 10.38 per share. | Direct | 73,481 | Dec 8, 2021 |
| HEATH-CHIOZZI MARGO Officer | Sale at price 40.00 per share. | Direct | 24,000 | Dec 8, 2021 |
| HEATH-CHIOZZI MARGO Officer | Conversion of Exercise of derivative security at price 2.78 per share. | Direct | 1,668 | Dec 8, 2021 |
| MARTIN SAMUEL BATES Chief Financial Officer | Sale at price 42.27 - 43.92 per share. | Direct | 413,883 | Nov 15, 2021 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 39,729 | Nov 15, 2021 |
| YOUNG DIANE C Officer | Sale at price 42.94 per share. | Direct | 197,529 | Nov 12, 2021 |
| YOUNG DIANE C Officer | Conversion of Exercise of derivative security at price 10.38 per share. | Direct | 47,748 | Nov 12, 2021 |
| CROWLEY ELIZABETH Officer | Sale at price 41.62 - 44.12 per share. | Direct | 186,874 | Nov 1, 2021 |
| CROWLEY ELIZABETH Officer | Conversion of Exercise of derivative security at price 2.78 per share. | Direct | 23,783 | Nov 1, 2021 |
| CAVANAUGH SARAH Officer | Sale at price 41.62 - 44.11 per share. | Direct | 316,804 | Nov 1, 2021 |
| CAVANAUGH SARAH Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 47,852 | Nov 1, 2021 |
| HEATH-CHIOZZI MARGO Officer | Sale at price 41.71 per share. | Direct | 25,026 | Nov 1, 2021 |
| HEATH-CHIOZZI MARGO Officer | Conversion of Exercise of derivative security at price 2.78 per share. | Direct | 1,668 | Nov 1, 2021 |
| HEATH-CHIOZZI MARGO Officer | Conversion of Exercise of derivative security at price 9.02 per share. | Direct | 90,165 | Aug 11, 2021 |
| JIMENEZ FREDDY A General Counsel | Purchase at price 46.28 per share. | Direct | 19,900 | Aug 11, 2021 |
| MARTIN SAMUEL BATES Chief Financial Officer | Sale at price 45.25 per share. | Direct | 123,894 | Aug 10, 2021 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 123,688 | Aug 10, 2021 |
| MARUCCI ANTHONY S Chief Executive Officer | Conversion of Exercise of derivative security at price 42.00 per share. | Direct | 148,554 | Aug 5, 2021 |
| WRIGHT RICHARD M Officer | Sale at price 18.61 per share. | Direct | 387,611 | Dec 14, 2020 |
| WRIGHT RICHARD M Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 129,365 | Dec 14, 2020 |
| YOUNG DIANE C Officer | Purchase at price 8.76 per share. | Direct | 18,517 | Jun 11, 2020 |
| CAVANAUGH SARAH Officer | Purchase at price 4.83 per share. | Direct | 5,072 | Jun 10, 2020 |
| MARINO JAMES J Director | Purchase at price 3.00 per share. | Direct | 24,915 | Jun 9, 2020 |
| KELER TIBOR Officer | Purchase at price 2.99 per share. | Direct | 14,954 | Jun 9, 2020 |
| MARUCCI ANTHONY S Chief Executive Officer | Purchase at price 3.06 per share. | Direct | 45,900 | Jun 9, 2020 |
| MARTIN SAMUEL BATES Chief Financial Officer | Purchase at price 3.05 per share. | Direct | 29,738 | Jun 9, 2020 |
| HEATH-CHIOZZI MARGO Officer | Purchase at price 3.00 per share. | Direct | 3,005 | Jun 9, 2020 |
| MARINO JAMES J Director | Purchase at price 0.48 per share. | Direct | 19,200 | Aug 24, 2018 |
| KELER TIBOR Officer | Purchase at price 0.59 per share. | Direct | 9,783 | Jun 15, 2018 |
| PENNER HARRY H JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2017 |
| CONRAD HERBERT J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2017 |
Related Tickers
MRUS Merus N.V.
45.04
+0.24%
MLTX MoonLake Immunotherapeutics
42.49
+0.57%
DNTH Dianthus Therapeutics, Inc.
21.50
+2.43%
ATXS Astria Therapeutics, Inc.
9.00
-1.85%
JSPR Jasper Therapeutics, Inc.
20.40
-3.68%
KPTI Karyopharm Therapeutics Inc.
1.0600
0.00%
IMVT Immunovant, Inc.
27.17
-2.09%
VERA Vera Therapeutics, Inc.
39.65
+2.48%
CABA Cabaletta Bio, Inc.
11.01
-9.61%
AFMD Affimed N.V.
5.03
+3.07%